As a diminished expression of TG2 in differentiating APL cells may attenuate the ATRA-induced systemic inflammatory response syndrome in DS, we further investigated the role of TG2 in limiting toxicities arising from DS. This evidence concerns the gene TGM2 and acute promyelocytic leukemia.